Avanos Medical Stock Buy Hold or Sell Recommendation
| AVNS Stock | USD 19.14 0.02 0.10% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Avanos Medical is 'Strong Hold'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Avanos Medical given historical horizon and risk tolerance towards Avanos Medical. When Macroaxis issues a 'buy' or 'sell' recommendation for Avanos Medical, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Avanos Medical Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy Avanos Stock please use our How to Invest in Avanos Medical guide. Note, we conduct extensive research on individual companies such as Avanos and provide practical buy, sell, or hold advice based on investors' constraints. Avanos Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Avanos |
Execute Avanos Medical Buy or Sell Advice
The Avanos recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Avanos Medical. Macroaxis does not own or have any residual interests in Avanos Medical or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Avanos Medical's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Hold
Market Performance | Very Weak | Details | |
Volatility | Not too volatile | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Actively responds to the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Avanos Medical Trading Alerts and Improvement Suggestions
| Avanos Medical generated a negative expected return over the last 90 days | |
| The company reported the previous year's revenue of 673.3 M. Net Loss for the year was (61.8 M) with profit before overhead, payroll, taxes, and interest of 450 M. | |
| Avanos Medical has a poor financial position based on the latest SEC disclosures | |
| Over 96.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from thelincolnianonline.com: Associated Banc Corp Sells 10,707 Shares of Avanos Medical, Inc. |
Avanos Medical Returns Distribution Density
The distribution of Avanos Medical's historical returns is an attempt to chart the uncertainty of Avanos Medical's future price movements. The chart of the probability distribution of Avanos Medical daily returns describes the distribution of returns around its average expected value. We use Avanos Medical price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Avanos Medical returns is essential to provide solid investment advice for Avanos Medical.
| Mean Return | -0.28 | Value At Risk | -2.71 | Potential Upside | 3.01 | Standard Deviation | 2.82 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Avanos Medical historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Avanos Stock Institutional Investors
The Avanos Medical's institutional investors refer to entities that pool money to purchase Avanos Medical's securities or originate loans. These institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds.
| Shares | Neuberger Berman Group Llc | 2024-06-30 | 998 K | Tributary Capital Management, Llc | 2024-06-30 | 743.1 K | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 718.2 K | Royal Bank Of Canada | 2024-06-30 | 587.9 K | Prudential Financial Inc | 2024-09-30 | 586.7 K | Charles Schwab Investment Management Inc | 2024-09-30 | 523.5 K | Northern Trust Corp | 2024-09-30 | 502 K | Bank Of New York Mellon Corp | 2024-06-30 | 382.2 K | D. E. Shaw & Co Lp | 2024-09-30 | 345.7 K | Blackrock Inc | 2024-06-30 | 7 M | Vanguard Group Inc | 2024-09-30 | 5.3 M |
Avanos Medical Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | (21.3M) | (21.8M) | 17.2M | (30.9M) | 4.7M | 4.9M | |
| Change In Cash | (179.2M) | (93.8M) | 7M | 9.2M | (40M) | (38M) | |
| Free Cash Flow | (125.1M) | (22.7M) | 66.3M | 71.6M | 14.6M | 13.9M | |
| Depreciation | 36.9M | 42.9M | 38.3M | 47.7M | 46.1M | 43.0M | |
| Other Non Cash Items | (9.9M) | 11.6M | 8M | 1.1M | 50.3M | 27.9M | |
| Capital Expenditures | 50.6M | 20.2M | 21M | 19.3M | 17.8M | 32.5M | |
| Net Income | (45.9M) | (27.2M) | 5.2M | 50.5M | (61.8M) | (58.7M) | |
| End Period Cash Flow | 205.3M | 111.5M | 118.5M | 127.7M | 87.7M | 148.9M | |
| Change To Netincome | 11.1M | 35.8M | 21.2M | 17M | 15.3M | 14.5M | |
| Change Receivables | (800K) | 45.8M | (10.8M) | (24.7M) | (22.2M) | (21.1M) | |
| Net Borrowings | (200K) | (69.8M) | (50M) | 100.5M | 90.5M | 95.0M | |
| Investments | (108.1M) | (4M) | (21M) | (135.4M) | (64.3M) | (61.1M) |
Avanos Medical Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Avanos Medical or Health Care Equipment & Supplies sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Avanos Medical's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Avanos stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.48 | |
β | Beta against Dow Jones | 1.63 | |
σ | Overall volatility | 2.87 | |
Ir | Information ratio | -0.14 |
Avanos Medical Volatility Alert
Avanos Medical exhibits very low volatility with skewness of -3.62 and kurtosis of 23.44. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Avanos Medical's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Avanos Medical's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Avanos Medical Fundamentals Vs Peers
Comparing Avanos Medical's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Avanos Medical's direct or indirect competition across all of the common fundamentals between Avanos Medical and the related equities. This way, we can detect undervalued stocks with similar characteristics as Avanos Medical or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Avanos Medical's fundamental indicators could also be used in its relative valuation, which is a method of valuing Avanos Medical by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Avanos Medical to competition |
| Fundamentals | Avanos Medical | Peer Average |
| Return On Equity | 0.0177 | -0.31 |
| Return On Asset | 0.0208 | -0.14 |
| Profit Margin | 0.02 % | (1.27) % |
| Operating Margin | 0.1 % | (5.51) % |
| Current Valuation | 1 B | 16.62 B |
| Shares Outstanding | 45.96 M | 571.82 M |
| Shares Owned By Insiders | 2.94 % | 10.09 % |
| Shares Owned By Institutions | 96.00 % | 39.21 % |
| Number Of Shares Shorted | 552.33 K | 4.71 M |
| Price To Earning | 51.23 X | 28.72 X |
| Price To Book | 0.72 X | 9.51 X |
| Price To Sales | 1.29 X | 11.42 X |
| Revenue | 673.3 M | 9.43 B |
| Gross Profit | 450 M | 27.38 B |
| EBITDA | 50.6 M | 3.9 B |
| Net Income | (61.8 M) | 570.98 M |
| Cash And Equivalents | 106.5 M | 2.7 B |
| Cash Per Share | 2.26 X | 5.01 X |
| Total Debt | 209.1 M | 5.32 B |
| Debt To Equity | 0.24 % | 48.70 % |
| Current Ratio | 2.89 X | 2.16 X |
| Book Value Per Share | 26.73 X | 1.93 K |
| Cash Flow From Operations | 32.4 M | 971.22 M |
| Short Ratio | 2.14 X | 4.00 X |
| Earnings Per Share | 0.47 X | 3.12 X |
| Price To Earnings To Growth | 2.29 X | 4.89 X |
| Target Price | 22.5 | |
| Number Of Employees | 3.77 K | 18.84 K |
| Beta | 0.93 | -0.15 |
| Market Capitalization | 880.54 M | 19.03 B |
| Total Asset | 1.69 B | 29.47 B |
| Retained Earnings | (314.9 M) | 9.33 B |
| Working Capital | 252.4 M | 1.48 B |
Note: Acquisition by Joseph Woody of 80933 shares of Avanos Medical subject to Rule 16b-3 [view details]
Avanos Medical Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Avanos . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Daily Balance Of Power | (9,223,372,036,855) | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 19.14 | |||
| Day Typical Price | 19.14 | |||
| Price Action Indicator | (0.01) | |||
| Period Momentum Indicator | (0.02) | |||
| Relative Strength Index | 34.41 |
About Avanos Medical Buy or Sell Advice
When is the right time to buy or sell Avanos Medical? Buying financial instruments such as Avanos Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Avanos Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Buywrite ETFs Thematic Idea Now
Buywrite ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Buywrite ETFs theme has 25 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Buywrite ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Avanos Stock Analysis
When running Avanos Medical's price analysis, check to measure Avanos Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avanos Medical is operating at the current time. Most of Avanos Medical's value examination focuses on studying past and present price action to predict the probability of Avanos Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avanos Medical's price. Additionally, you may evaluate how the addition of Avanos Medical to your portfolios can decrease your overall portfolio volatility.